Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication is a research paper published in Viruses (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21AI138598
National Institutes of Health
Grant: R21AI157909
National Institutes of Health
Grant: R15AG069544
National Institutes of Health
Grant: 1I01BX002670
National Institutes of Health
Grant: 1I01BX004281
National Institutes of Health
Grant: 5I01BX005428–02
National Institutes of Health
Grant: PR170067
NIH HHS
Grant: S10 OD021572
BLRD VA
Grant: I01 BX002670
VA
Grant: 5I01BX005428-02
COVID-19: Characterizing trained immune responses to COVID-19
BLRD VA
Grant: I01 BX004281
NIAID NIH HHS
Grant: R21 AI179794
BLRD VA
Grant: I01 BX005428
National Institutes of Health
Grant: 5I01BX002670-04
Premature T cell aging and vaccine failure in chronic viral infection
National Institutes of Health
Grant: 1R21AI138598-01A1
Telomere loss and T cell aging in HBV vaccine response in HIV-infected individual
National Institutes of Health
Grant: 3R15AG069544-01A1S1
Mitochondrial Dysfunction in Aging CD4 T cells in HIV-immune Non-responders.
National Institutes of Health
Grant: 1I01BX005428-01
COVID-19: Characterizing trained immune responses to COVID-19
National Institutes of Health
Grant: 1I01BX004281-01A1
Telomere loss and T cell aging in HBV vaccine response in HCV-infected individual
National Institutes of Health
Grant: 5R21AI157909-02
Dual specific gene editing drugs delivered by nanoparticles targeting HBV/HIV coinfection
FWCI
0.86
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals